scispace - formally typeset
Open AccessJournal ArticleDOI

MicroRNA-24 Regulates Vascularity After Myocardial Infarction

Reads0
Chats0
TLDR
It is shown that the small noncoding RNA microRNA-24 (miR-24) is enriched in cardiac endothelial cells and considerably upregulated after cardiac ischemia, and is suitable for therapeutic intervention in the setting of ischemic heart disease.
Abstract
Background—Myocardial infarction leads to cardiac remodeling and development of heart failure. Insufficient myocardial capillary density after myocardial infarction has been identified as a critical event in this process, although the underlying mechanisms of cardiac angiogenesis are mechanistically not well understood. Methods and Results—Here, we show that the small noncoding RNA microRNA-24 (miR-24) is enriched in cardiac endothelial cells and considerably upregulated after cardiac ischemia. MiR-24 induces endothelial cell apoptosis, abolishes endothelial capillary network formation on Matrigel, and inhibits cell sprouting from endothelial spheroids. These effects are mediated through targeting of the endothelium-enriched transcription factor GATA2 and the p21-activated kinase PAK4, which were identified by bioinformatic predictions and validated by luciferase gene reporter assays. Respective downstream signaling cascades involving phosphorylated BAD (Bcl-XL/Bcl-2–associated death promoter) and Sirtuin...

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches

TL;DR: This review guides the reader through important aspects of non-coding RNA biology, including their biogenesis, mode of actions, physiological function, as well as their role in the disease context (such as in cancer or the cardiovascular system).
Journal ArticleDOI

MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles

TL;DR: The pharmacokinetic and pharmacodynamic properties of current antimiR designs and their relevance to cardiovascular indications are focused on, and the opportunities and obstacles associated with this new therapeutic modality are evaluated.
Journal ArticleDOI

Animal Models of Heart Failure A Scientific Statement From the American Heart Association

TL;DR: The distinctive clinical features of the major causes of HF in humans are defined and those distinctive pathological features ofHF in humans that should be present in an animal model being used to identify fundamental causes ofHF or to test preventative or reparative therapies that could reduce HF morbidity and mortality are recommended.
References
More filters
Journal ArticleDOI

The functions of animal microRNAs

TL;DR: Evidence is mounting that animal miRNAs are more numerous, and their regulatory impact more pervasive, than was previously suspected.
Journal ArticleDOI

Silencing of microRNAs in vivo with ‘antagomirs’

TL;DR: It is shown that a novel class of chemically engineered oligonucleotides, termed ‘antagomirs’, are efficient and specific silencers of endogenous miRNA levels in mice and may represent a therapeutic strategy for silencing miRNAs in disease.
Journal ArticleDOI

A mammalian microRNA expression atlas based on small RNA library sequencing.

TL;DR: A relatively small set of miRNAs, many of which are ubiquitously expressed, account for most of the differences in miRNA profiles between cell lineages and tissues.
Related Papers (5)